1. Home
  2. LSTR vs GRFS Comparison

LSTR vs GRFS Comparison

Compare LSTR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Landstar System Inc.

LSTR

Landstar System Inc.

HOLD

Current Price

$166.93

Market Cap

5.1B

Sector

Industrials

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.02

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSTR
GRFS
Founded
1988
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.8B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
LSTR
GRFS
Price
$166.93
$8.02
Analyst Decision
Hold
Hold
Analyst Count
13
2
Target Price
$153.67
$10.15
AVG Volume (30 Days)
348.7K
752.7K
Earning Date
04-28-2026
07-28-2022
Dividend Yield
2.18%
1.73%
EPS Growth
N/A
N/A
EPS
3.31
N/A
Revenue
$4,743,760,000.00
N/A
Revenue This Year
$6.67
$5.33
Revenue Next Year
$9.06
$6.50
P/E Ratio
$49.94
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$119.40
$6.19
52 Week High
$166.11
$11.14

Technical Indicators

Market Signals
Indicator
LSTR
GRFS
Relative Strength Index (RSI) 68.86 47.16
Support Level $142.52 $7.52
Resistance Level N/A $9.11
Average True Range (ATR) 4.96 0.22
MACD 1.55 0.10
Stochastic Oscillator 87.35 71.28

Price Performance

Historical Comparison
LSTR
GRFS

About LSTR Landstar System Inc.

Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: